doxycycline monohydrate 5 MG/ML Oral Suspension
- RxCUI
- 1650030
- RxNorm name
- doxycycline monohydrate 5 MG/ML Oral Suspension
- Display name
- Doxycycline (Oral Liquid)
- Full name
- doxycycline monohydrate 5 MG/ML Oral Suspension
- Term type
- SCD
- Status
- Active
- Strength
- 25 mg/5ml
- Dose form
- Susp
- Route
- Oral Liquid
- Updated
- 2026-11-06 11:38:19
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 062015
- Active start
- 062015
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| doxycycline monohydrate | 5 MG / 1 ML | doxycycline | doxycycline |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Suspension | 316969 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| doxycycline | 3640 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | doxycycline monohydrate 5 MG/ML Oral Suspension | 1 | NAMES |
| RxNorm Name | doxycycline monohydrate 5 MG/ML Oral Suspension | 1 | NAMES |
| RxNorm Synonym | doxycycline monohydrate 25 MG per 5 ML Oral Suspension | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 3 | CODES | |
| RxCUI | 1650030 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 62135-417-46 | 62135-417 | doxycycline doxycycline | Chartwell RX LLC | ANDA065454 |
| 62135-877-46 | 62135-877 | doxycycline doxycycline | Chartwell RX LLC | ANDA065454 |
| 68180-657-01 | 68180-657 | DOXYCYCLINE DOXYCYCLINE | Lupin Pharmaceuticals, Inc. | ANDA201678 |
| 68999-417-46 | 68999-417 | doxycycline doxycycline | Chartwell Governmental & Specialty RX, LLC | ANDA065454 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA065454 | 62135-417 | doxycycline doxycycline | ANDA | Chartwell RX LLC |
| ANDA201678 | 68180-657 | DOXYCYCLINE DOXYCYCLINE | ANDA | Lupin Pharmaceuticals, Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| doxycycline | DOXYCYCLINE | Chartwell RX LLC | 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | 2026-10-16 | Warnings, Adverse reactions | 62135-877-46 62135-417-46 62135-877 62135-417 62135087746 62135041746 1650030 |
| DOXYCYCLINE | DOXYCYCLINE | Lupin Pharmaceuticals, Inc. | e0e80435-1b6a-4361-8c8a-e432f8f23a1b | 2025-10-23 | Warnings, Adverse reactions | 68180-657-01 68180-657 68180065701 1650030 |
| doxycycline | DOXYCYCLINE | Chartwell Governmental & Specialty RX, LLC | b8486639-7eb9-4610-9cd4-0e922045d592 | 2025-09-30 | Warnings, Adverse reactions | 68999-417-46 68999-417 68999041746 1650030 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e0e80435-1b6a-4361-8c8a-e432f8f23a1b | doxycycline monohydrate 25 MG in 5 mL Oral Suspension [PSN] · doxycycline monohydrate 5 MG/ML Oral Suspension [SCD] · doxycycline monohydrate 25 MG per 5 ML Oral Suspension [SY] | 3 | 21 | DOXYCYCLINE FOR ORAL SUSPENSION USP | 20251023 |
| 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | doxycycline monohydrate 25 MG in 5 mL Oral Suspension [PSN] · doxycycline monohydrate 5 MG/ML Oral Suspension [SCD] · doxycycline monohydrate 25 MG per 5 ML Oral Suspension [SY] | 3 | 16 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | 20250930 |
| b8486639-7eb9-4610-9cd4-0e922045d592 | doxycycline monohydrate 25 MG in 5 mL Oral Suspension [PSN] · doxycycline monohydrate 5 MG/ML Oral Suspension [SCD] · doxycycline monohydrate 25 MG per 5 ML Oral Suspension [SY] | 3 | 10 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | 20250930 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | Chartwell RX LLC | 20261016 |
| 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | Chartwell RX LLC | 20260929 |
| e0e80435-1b6a-4361-8c8a-e432f8f23a1b | DOXYCYCLINE FOR ORAL SUSPENSION USP | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 20251023 |
| 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | Chartwell RX LLC | 20250930 |
| b8486639-7eb9-4610-9cd4-0e922045d592 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | Chartwell Governmental & Specialty RX, LLC | 20250930 |
| e0e80435-1b6a-4361-8c8a-e432f8f23a1b | DOXYCYCLINE FOR ORAL SUSPENSION USP | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 20250924 |
| e0e80435-1b6a-4361-8c8a-e432f8f23a1b | DOXYCYCLINE FOR ORAL SUSPENSION USP | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 20250908 |
| d6f98d3c-5a20-4cbf-9a9c-abef10b9e465 | Vibramycin ® Calcium (doxycycline calcium oral suspension, USP) oral suspension SYRUP Vibramycin ® Hyclate (doxycycline hyclate capsules, USP) CAPSULES Vibramycin ® Monohydrate (doxycycline monohydrate) for ORAL SUSPENSION Vibra-Tabs ® (doxycycline hyclate tablets, USP) FILM COATED TABLETS | Pfizer Laboratories Div Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals | Pfizer Inc | 20240716 |
| 10ef2080-8718-4ab9-8450-a28773e0247a | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | Chartwell RX LLC | Chartwell Pharmaceuticals LLC | 20191230 |
| 9df39880-b2a7-483f-bbc3-c0be67492388 | DOXYCYCLINE FOR ORAL SUSPENSION, USP | CIPLA USA, Inc | Chartwell Pharmaceuticals | 20170223 |
| d6fe44ca-5e4d-4a5f-a7fd-e4c39866444a | DOXYCYCLINE FOR ORAL SUSPENSION, USP | Harris Pharmaceutical, Inc | 20170223 |
| 2439a728-4088-43af-b016-0a681ac904e7 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A01AB | Antiinfectives and antiseptics for local oral treatment | ATC1-4 | doxycycline | |
| ATC | J01AA | Tetracyclines | ATC1-4 | doxycycline | |
| FDASPL | D013754 | Tetracyclines | CHEM | has_chemical_structure | doxycycline |
| FDASPL | N0000175882 | Tetracycline-class Drug | EPC | has_epc | doxycycline |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline monohydrate |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline monohydrate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline monohydrate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline monohydrate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline monohydrate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline monohydrate |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline monohydrate |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline monohydrate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline monohydrate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline monohydrate |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline monohydrate |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline monohydrate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA065454 |
| CODES | ANDA | ANDA201678 |
| CODES | VUID | 4001961 |
| NAMES | Prescribable Synonym | doxycycline monohydrate 25 MG in 5 mL Oral Suspension |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |